Life Line Screening

Life Line Screening: preventive health screening in the United States

Life Line Screening is an American company dedicated to preventive health screening. Since 1993, it has brought clinical screening tests to communities across the country, with more than 11 million people screened and a network of 15,000 locations. Its work focuses on identifying cardiovascular, stroke and other condition risks before symptoms appear.

Screening tests and packages

The company offers various screening packages, all physician-reviewed and eligible for HSA/FSA health accounts. Prices start at $186. The Heart & Stroke Risk package includes four essential tests: carotid artery, aortic aneurysm, arterial disease and atrial fibrillation. The Chronic Disease Risk package expands to ten tests, adding a comprehensive chronic disease risk assessment. The Men's & Women's Health package adds up to fifteen tests, with liver and kidney analysis, hormone levels, organ health and A1C. The Complete Preventative Care Suite, the most comprehensive, offers nineteen tests and a mid-year follow-up.

OneLife Membership

For those who prioritize their health year after year, the OneLife membership allows annual screenings and building a personal health record. It includes free osteoporosis and cortisol tests (valued at $158), a $30 credit toward any screening enhancement, live clinical results consultation, priority scheduling with no change fees and discounts for family members.

Process and accessibility

The process begins by booking an appointment at community locations such as churches or community centers, with no medical referral or insurance required. The appointment lasts about an hour, is painless and non-invasive, performed by technicians specialized in ultrasound imaging, electrocardiogram and blood analysis. Results, reviewed by a board-certified physician, are available online within ten days and explained in plain language.

History and milestones

Founded in 1993, Life Line Screening expanded its national presence in 1998. In 2007 it incorporated finger-stick tests for cholesterol, diabetes and inflammation. In 2013, independent researchers from Oxford and the American College of Cardiology published studies based on its data. In 2025, the company identified more than 125,000 critical findings in a single year.

Team and clinical approach

In-house technicians are specifically trained in ultrasound imaging, EKG and blood analysis. Every result is reviewed by a board-certified physician before being delivered to the client. The company combines clinical rigor with personal care, and its vascular tests are not typically available in routine primary care visits.